Top insider buys: Aug 28 – Sep 3, 2023

The largest open-market purchases company insiders reported on SEC Form 4 between Aug 28 – Sep 3, 2023.

Week 35, 2023

#	Company	Who bought	Shares	Value	Source
1	SPRY ARS Pharmaceuticals, Inc.	3 officers/directors Cluster buy RA CAPITAL MANAGEMENT, L.P., ORBIMED ADVISORS LLC, Peter A. Thompson	4,750,000	$29.4M	SEC filings
2	SOWG Sow Good Inc.	3 officers/directors Cluster buy Claudia Goldfarb, Lyle Berman, Ira Goldfarb	280,000	$1.4M	SEC filings
3	ZBH ZIMMER BIOMET HOLDINGS, INC.	4 officers/directors Cluster buy Sreelakshmi Kolli, Robert Hagemann, Michael W. Michelson, Betsy J. Bernard	5,321	$620K	SEC filings
4	VVV VALVOLINE INC	3 officers/directors Cluster buy Richard Joseph Freeland, Lori Ann Flees, Mary E. Meixelsperger	17,839	$602K	SEC filings
5	PI IMPINJ INC	Director Daniel Patrick Gibson	155,006	$9.8M	SEC filings
6	IHT INNSUITES HOSPITALITY TRUST	2 separate filers Jr Chase, James F. Wirth	4,140	$8.5M	SEC filings
7	ASAN Asana, Inc.	President, CEO, & Chair Dustin A. Moskovitz	320,000	$6.9M	SEC filings
8	DSGN Design Therapeutics, Inc.	Director Arsani William	2,235,000	$5.4M	SEC filings
9	ECAT BlackRock ESG Capital Allocation Term Trust	10% Owner Saba Capital Management, L.P.	347,186	$5.3M	SEC filings
10	DCOM Dime Community Bancshares, Inc. /NY/	Director BASSWOOD CAPITAL MANAGEMENT, L.L.C.	231,286	$5.0M	SEC filings

Source: SEC Form 4 filings, aggregated per company over the week. Open-market purchases of $100K or more only; grants, awards, option exercises and likely IPO or offering allocations are excluded. Cluster buys (two or more officers or directors buying) rank first, then by dollar value.

Not investment advice. This page reports public SEC data and is not a recommendation to buy or sell any security.